Pinjie Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pinjie Huang has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Chaojin Chen
Department of Anesthesiology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
4 shared publications - Shaoli Zhou
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
4 shared publications - Weifeng Yao
Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
3 shared publications Xiaoyu Lin
Department of Anaesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou, Guangdong Province, 510630, China
3 shared publicationsXue Han
Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510000, China
3 shared publications- Ziqing Hei
Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
3 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Bilevel positive airway pressure reduces anaesthesiologist workload and turnover time in electroconvulsive therapy: a randomized controlled trial
The increasing clinical demand for electroconvulsive therapy (ECT) highlights specific challenges in anaesthetic management, particularly the reliance on continuous mask ventilation. Bilevel positive airway pressure (BPAP) provides automated, hands-free ventilatory support and may enhance efficiency. This study aims to compare the impact of BPAP versus face mask ventilation on procedural turnover time during ECT. In this single-blind, randomized controlled trial, 110 patients were enrolled with a history of at least two prior ECT sessions. Participants were randomly allocated to receive either BPAP or face mask ventilation. The primary outcome was the turnover time, defined as the duration from anaesthesia induction to entry into the post-anaesthesia care unit (PACU). Secondary outcomes included the total ECT duration, breathing and consciousness recovery times, incidence of hypoxemia (SpO2 < 94% for > 5 s), adverse events and operator-centered measures, including upper limb discomfort, anxiety and satisfaction scores. The BPAP group demonstrated a significantly shorter median turnover time ccompared to the face mask group (332 [286-415] s vs. 426 [348-472] s; median difference 84 s, 95% CI 44-119, P < 0.001). No significant differences in the total ECT duration, breathing recovery time, consciousness recovery time, or incidence of hypoxemia. The incidence of anaesthesiologist-reported upper limb discomfort was lower in the BPAP group (P < 0.001), and operator satisfaction scores were higher (P < 0.001). In patients with prior ECT experience, BPAP safely reduced procedural turnover time and significantly decreased the physical burden on anaesthesiologists compared to face mask ventilation. BPAP represents a viable strategy to improve workflow efficiency and operator comfort in high-volume ECT settings. ChiCTR2100051837, the Chinese Clinical Trial, 20-211-006. Research registration number: ChiCTR2100051837, the Chinese Clinical Trial Registry. IRB number: [2021] 02-203-01, the Research Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- 6 July 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessBilevel positive airway pressure reduces anaesthesiologist workload and turnover time in electroconvulsive therapy: a randomized controlled trial
The increasing clinical demand for electroconvulsive therapy (ECT) highlights specific challenges in anaesthetic management, particularly the reliance on continuous mask ventilation. Bilevel positive airway pressure (BPAP) provides automated, hands-free ventilatory support and may enhance efficiency. This study aims to compare the impact of BPAP versus face mask ventilation on procedural turnover time during ECT. In this single-blind, randomized controlled trial, 110 patients were enrolled with a history of at least two prior ECT sessions. Participants were randomly allocated to receive either BPAP or face mask ventilation. The primary outcome was the turnover time, defined as the duration from anaesthesia induction to entry into the post-anaesthesia care unit (PACU). Secondary outcomes included the total ECT duration, breathing and consciousness recovery times, incidence of hypoxemia (SpO2 < 94% for > 5 s), adverse events and operator-centered measures, including upper limb discomfort, anxiety and satisfaction scores. The BPAP group demonstrated a significantly shorter median turnover time ccompared to the face mask group (332 [286-415] s vs. 426 [348-472] s; median difference 84 s, 95% CI 44-119, P < 0.001). No significant differences in the total ECT duration, breathing recovery time, consciousness recovery time, or incidence of hypoxemia. The incidence of anaesthesiologist-reported upper limb discomfort was lower in the BPAP group (P < 0.001), and operator satisfaction scores were higher (P < 0.001). In patients with prior ECT experience, BPAP safely reduced procedural turnover time and significantly decreased the physical burden on anaesthesiologists compared to face mask ventilation. BPAP represents a viable strategy to improve workflow efficiency and operator comfort in high-volume ECT settings. ChiCTR2100051837, the Chinese Clinical Trial, 20-211-006. Research registration number: ChiCTR2100051837, the Chinese Clinical Trial Registry. IRB number: [2021] 02-203-01, the Research Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Open Access
Tailored lymph node dissection in right hemicolectomy: a retrospective study focusing on the anterior tissue of the superior mesenteric vein surgical trunk
Background: The optimal extent of lymph node dissection in right hemicolectomy for colon cancer remains a topic of debate. This study aimed to refine lymph node dissection strategies by investigating the histopathological characteristics of the anterior tissue of the superior mesenteric vein (SMV) surgical trunk. Methods: One hundred sixty-two patients underwent surgery, with their medial resection border determined to be either to the right or left of the SMV. Pathological and perioperative variables were assessed, and the anterior tissue of the SMV was analyzed to quantify lymph nodes and nerve fibers. Results: Of the patients included, 84 were in the SMV-right group and 78 in the SMV-left group. After propensity score matching (PSM), the SMV-left group with dissection extending to the left side of the SMV and removal of the anterior tissue of SMV surgical trunk, retrieved more lymph nodes (36.9 vs. 26.8, P < 0.001) than the SMV-right group. However, there was no difference in node-positive staging. The SMV-left group also experienced more postoperative complications (16.7% vs. 1.7%, P = 0.011) and prolonged postoperative defecation times (4.2 vs. 3.5, P = 0.035), accompanied by a higher resection of nerve fibers (12.1 ± 4.2/case). Multivariate analysis identified tumor location above the ileocolic vein (ICV) root and elevated preoperative CA 19-9 levels as independent risk factors for metastasis to main lymph nodes. Conclusion: Right hemicolectomy with extended lymph node dissection improves lymph node retrieval but increases complication risks and prolongs bowel recovery time. For patients with tumors located below the ICV root, a more limited dissection with the right side of the SMV as the medial boundary may be a preferable option, given the low rate of main lymph node metastasis.
Open AccessTailored lymph node dissection in right hemicolectomy: a retrospective study focusing on the anterior tissue of the superior mesenteric vein surgical trunk
Background: The optimal extent of lymph node dissection in right hemicolectomy for colon cancer remains a topic of debate. This study aimed to refine lymph node dissection strategies by investigating the histopathological characteristics of the anterior tissue of the superior mesenteric vein (SMV) surgical trunk. Methods: One hundred sixty-two patients underwent surgery, with their medial resection border determined to be either to the right or left of the SMV. Pathological and perioperative variables were assessed, and the anterior tissue of the SMV was analyzed to quantify lymph nodes and nerve fibers. Results: Of the patients included, 84 were in the SMV-right group and 78 in the SMV-left group. After propensity score matching (PSM), the SMV-left group with dissection extending to the left side of the SMV and removal of the anterior tissue of SMV surgical trunk, retrieved more lymph nodes (36.9 vs. 26.8, P < 0.001) than the SMV-right group. However, there was no difference in node-positive staging. The SMV-left group also experienced more postoperative complications (16.7% vs. 1.7%, P = 0.011) and prolonged postoperative defecation times (4.2 vs. 3.5, P = 0.035), accompanied by a higher resection of nerve fibers (12.1 ± 4.2/case). Multivariate analysis identified tumor location above the ileocolic vein (ICV) root and elevated preoperative CA 19-9 levels as independent risk factors for metastasis to main lymph nodes. Conclusion: Right hemicolectomy with extended lymph node dissection improves lymph node retrieval but increases complication risks and prolongs bowel recovery time. For patients with tumors located below the ICV root, a more limited dissection with the right side of the SMV as the medial boundary may be a preferable option, given the low rate of main lymph node metastasis.
- Open Access
- 3 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e68354
Machine Learning–Based Prediction of Early Complications Following Surgery for Intestinal Obstruction: Multicenter Retrospective Study
Background: Early complications increase in-hospital stay and mortality after intestinal obstruction surgery. It is important to identify the risk of postoperative early complications for patients with intestinal obstruction at a sufficiently early stage, which would allow preemptive individualized enhanced therapy to be conducted to improve the prognosis of patients with intestinal obstruction. A risk predictive model based on machine learning is helpful for early diagnosis and timely intervention. Objective: This study aimed to construct an online risk calculator for early postoperative complications in patients after intestinal obstruction surgery based on machine learning algorithms. Methods: A total of 396 patients undergoing intestinal obstruction surgery from April 2013 to April 2021 at an independent medical center were enrolled as the training cohort. Overall, 7 machine learning methods were used to establish prediction models, with their performance appraised via the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, specificity, and F1-score. The best model was validated through 2 independent medical centers, a publicly available perioperative dataset the Informative Surgical Patient dataset for Innovative Research Environment (INSPIRE), and a mixed cohort consisting of the above 3 datasets, involving 50, 66, 48, and 164 cases, respectively. Shapley Additive Explanations were measured to identify risk factors. Results: The incidence of postoperative complications in the training cohort was 47.44% (176/371), while the incidences in 4 external validation cohorts were 34% (17/50), 56.06% (37/66), 52.08% (25/48), and 48.17% (79/164), respectively. Postoperative complications were associated with 8-item features: Physiological Severity Score for the Enumeration of Mortality and Morbidity (POSSUM physiological score), the amount of colloid infusion, shock index before anesthesia induction, ASA (American Society of Anesthesiologists) classification, the percentage of neutrophils, shock index at the end of surgery, age, and total protein. The random forest model showed the best overall performance, with an AUROC of 0.788 (95% CI 0.709-0.869), accuracy of 0.756, sensitivity of 0.695, specificity of 0.810, and F1-score of 0.727 in the training cohort. The random forest model also achieved a comparable AUROC of 0.755 (95% CI 0.652-0.839) in validation cohort 1, a greater AUROC of 0.817 (95% CI 0.695-0.913) in validation cohort 2, a similar AUROC of 0.786 (95% CI 0.628-0.902) in validation cohort 3, and the comparable AUROC of 0.720 (95% CI 0.671-0.768) in validation cohort 4. We visualized the random forest model and created a web-based online risk calculator. Conclusions: We have developed and validated a generalizable random forest model to predict postoperative early complications in patients undergoing intestinal obstruction surgery, enabling clinicians to screen high-risk patients and implement early individualized interventions. An online risk calculator for early postoperative complications was developed to make the random forest model accessible to clinicians around the world.
- 3 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e68354
Open AccessMachine Learning–Based Prediction of Early Complications Following Surgery for Intestinal Obstruction: Multicenter Retrospective Study
Background: Early complications increase in-hospital stay and mortality after intestinal obstruction surgery. It is important to identify the risk of postoperative early complications for patients with intestinal obstruction at a sufficiently early stage, which would allow preemptive individualized enhanced therapy to be conducted to improve the prognosis of patients with intestinal obstruction. A risk predictive model based on machine learning is helpful for early diagnosis and timely intervention. Objective: This study aimed to construct an online risk calculator for early postoperative complications in patients after intestinal obstruction surgery based on machine learning algorithms. Methods: A total of 396 patients undergoing intestinal obstruction surgery from April 2013 to April 2021 at an independent medical center were enrolled as the training cohort. Overall, 7 machine learning methods were used to establish prediction models, with their performance appraised via the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, specificity, and F1-score. The best model was validated through 2 independent medical centers, a publicly available perioperative dataset the Informative Surgical Patient dataset for Innovative Research Environment (INSPIRE), and a mixed cohort consisting of the above 3 datasets, involving 50, 66, 48, and 164 cases, respectively. Shapley Additive Explanations were measured to identify risk factors. Results: The incidence of postoperative complications in the training cohort was 47.44% (176/371), while the incidences in 4 external validation cohorts were 34% (17/50), 56.06% (37/66), 52.08% (25/48), and 48.17% (79/164), respectively. Postoperative complications were associated with 8-item features: Physiological Severity Score for the Enumeration of Mortality and Morbidity (POSSUM physiological score), the amount of colloid infusion, shock index before anesthesia induction, ASA (American Society of Anesthesiologists) classification, the percentage of neutrophils, shock index at the end of surgery, age, and total protein. The random forest model showed the best overall performance, with an AUROC of 0.788 (95% CI 0.709-0.869), accuracy of 0.756, sensitivity of 0.695, specificity of 0.810, and F1-score of 0.727 in the training cohort. The random forest model also achieved a comparable AUROC of 0.755 (95% CI 0.652-0.839) in validation cohort 1, a greater AUROC of 0.817 (95% CI 0.695-0.913) in validation cohort 2, a similar AUROC of 0.786 (95% CI 0.628-0.902) in validation cohort 3, and the comparable AUROC of 0.720 (95% CI 0.671-0.768) in validation cohort 4. We visualized the random forest model and created a web-based online risk calculator. Conclusions: We have developed and validated a generalizable random forest model to predict postoperative early complications in patients undergoing intestinal obstruction surgery, enabling clinicians to screen high-risk patients and implement early individualized interventions. An online risk calculator for early postoperative complications was developed to make the random forest model accessible to clinicians around the world.
- Open Access
- 4 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Machine Learning–Based Prediction of Early Complications Following Surgery for Intestinal Obstruction: Multicenter Retrospective Study (Preprint)
BACKGROUND Early complications increase in-hospital stay and mortality after intestinal obstruction surgery. It is important to identify the risk of postoperative early complications for patients with intestinal obstruction at a sufficiently early stage, which would allow preemptive individualized enhanced therapy to be conducted to improve the prognosis of patients with intestinal obstruction. A risk predictive model based on machine learning is helpful for early diagnosis and timely intervention. OBJECTIVE This study aimed to construct an online risk calculator for early postoperative complications in patients after intestinal obstruction surgery based on machine learning algorithms. METHODS A total of 396 patients undergoing intestinal obstruction surgery from April 2013 to April 2021 at an independent medical center were enrolled as the training cohort. Overall, 7 machine learning methods were used to establish prediction models, with their performance appraised via the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, specificity, and F1-score. The best model was validated through 2 independent medical centers, a publicly available perioperative dataset the Informative Surgical Patient dataset for Innovative Research Environment (INSPIRE), and a mixed cohort consisting of the above 3 datasets, involving 50, 66, 48, and 164 cases, respectively. Shapley Additive Explanations were measured to identify risk factors. RESULTS The incidence of postoperative complications in the training cohort was 47.44% (176/371), while the incidences in 4 external validation cohorts were 34% (17/50), 56.06% (37/66), 52.08% (25/48), and 48.17% (79/164), respectively. Postoperative complications were associated with 8-item features: Physiological Severity Score for the Enumeration of Mortality and Morbidity (POSSUM physiological score), the amount of colloid infusion, shock index before anesthesia induction, ASA (American Society of Anesthesiologists) classification, the percentage of neutrophils, shock index at the end of surgery, age, and total protein. The random forest model showed the best overall performance, with an AUROC of 0.788 (95% CI 0.709-0.869), accuracy of 0.756, sensitivity of 0.695, specificity of 0.810, and F1-score of 0.727 in the training cohort. The random forest model also achieved a comparable AUROC of 0.755 (95% CI 0.652-0.839) in validation cohort 1, a greater AUROC of 0.817 (95% CI 0.695-0.913) in validation cohort 2, a similar AUROC of 0.786 (95% CI 0.628-0.902) in validation cohort 3, and the comparable AUROC of 0.720 (95% CI 0.671-0.768) in validation cohort 4. We visualized the random forest model and created a web-based online risk calculator. CONCLUSIONS We have developed and validated a generalizable random forest model to predict postoperative early complications in patients undergoing intestinal obstruction surgery, enabling clinicians to screen high-risk patients and implement early individualized interventions. An online risk calculator for early postoperative complications was developed to make the random forest model accessible to clinicians around the world. CLINICALTRIAL
- 4 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMachine Learning–Based Prediction of Early Complications Following Surgery for Intestinal Obstruction: Multicenter Retrospective Study (Preprint)
BACKGROUND Early complications increase in-hospital stay and mortality after intestinal obstruction surgery. It is important to identify the risk of postoperative early complications for patients with intestinal obstruction at a sufficiently early stage, which would allow preemptive individualized enhanced therapy to be conducted to improve the prognosis of patients with intestinal obstruction. A risk predictive model based on machine learning is helpful for early diagnosis and timely intervention. OBJECTIVE This study aimed to construct an online risk calculator for early postoperative complications in patients after intestinal obstruction surgery based on machine learning algorithms. METHODS A total of 396 patients undergoing intestinal obstruction surgery from April 2013 to April 2021 at an independent medical center were enrolled as the training cohort. Overall, 7 machine learning methods were used to establish prediction models, with their performance appraised via the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, specificity, and F1-score. The best model was validated through 2 independent medical centers, a publicly available perioperative dataset the Informative Surgical Patient dataset for Innovative Research Environment (INSPIRE), and a mixed cohort consisting of the above 3 datasets, involving 50, 66, 48, and 164 cases, respectively. Shapley Additive Explanations were measured to identify risk factors. RESULTS The incidence of postoperative complications in the training cohort was 47.44% (176/371), while the incidences in 4 external validation cohorts were 34% (17/50), 56.06% (37/66), 52.08% (25/48), and 48.17% (79/164), respectively. Postoperative complications were associated with 8-item features: Physiological Severity Score for the Enumeration of Mortality and Morbidity (POSSUM physiological score), the amount of colloid infusion, shock index before anesthesia induction, ASA (American Society of Anesthesiologists) classification, the percentage of neutrophils, shock index at the end of surgery, age, and total protein. The random forest model showed the best overall performance, with an AUROC of 0.788 (95% CI 0.709-0.869), accuracy of 0.756, sensitivity of 0.695, specificity of 0.810, and F1-score of 0.727 in the training cohort. The random forest model also achieved a comparable AUROC of 0.755 (95% CI 0.652-0.839) in validation cohort 1, a greater AUROC of 0.817 (95% CI 0.695-0.913) in validation cohort 2, a similar AUROC of 0.786 (95% CI 0.628-0.902) in validation cohort 3, and the comparable AUROC of 0.720 (95% CI 0.671-0.768) in validation cohort 4. We visualized the random forest model and created a web-based online risk calculator. CONCLUSIONS We have developed and validated a generalizable random forest model to predict postoperative early complications in patients undergoing intestinal obstruction surgery, enabling clinicians to screen high-risk patients and implement early individualized interventions. An online risk calculator for early postoperative complications was developed to make the random forest model accessible to clinicians around the world. CLINICALTRIAL
- Open Access
- 1 June 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 2381-2392
Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study
Purpose: We aimed to evaluate the effect of intravenous esketamine combined with dexmedetomidine as supplemental analgesia in reducing intraoperative visceral pain during elective cesarean section under combined spinal-epidural anesthesia (CSEA). Patients and Methods: A total of 269 parturients scheduled for elective cesarean section under CSEA between May 2023 and August 2023 were assessed. The parturients were randomly allocated to receiving either intravenous infusion of 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine (group ED, n=76), 0.5-μg/kg dexmedetomidine (group D, n=76), or normal saline (group C, n=76) after umbilical cord clamping. The primary outcome was intraoperative visceral pain. Secondary outcomes included the visual analog scale (VAS) score for pain evaluation and other intraoperative complications. Results: The incidence of visceral pain was lower in group ED [9 (12.7%)] than in group D [32 (43.8%)] and group C [36 (48.6%), P < 0.0001]. The VAS score was also lower in group ED when exploring abdominal cavity [0 (0), P < 0.0001] and suturing the muscle layer [0 (0), P =0.036]. The mean arterial pressure was higher in group D [83 (9) mmHg] and group ED [81 (11) mmHg] than in group C [75 (10) mmHg, P < 0.0001] after solution infusion. The heart rate after infusion of the solution was lower in group D [80 (12) bpm] than in group C [86 (14) bpm] and group ED [85 (12) bpm, P = 0.016]. The incidence of transient neurologic or mental symptoms was higher in group ED compared to group C and group D (76.1% vs 18.9% vs 23.3%, P< 0.0001). Conclusion: During cesarean section, 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine can alleviate visceral traction pain and provide stable hemodynamics. Parturients receiving this regimen may experience transient neurologic or mental symptoms that can spontaneously resolve at the end of the surgery. Plain Language Summary: Some parturients endure experience indescribable pain and discomfort during fetal delivery. Esketamine combined with dexmedetomidine can alleviate this pain during cesarean section under combined spinal-epidural anesthesia. However, after intravenous injection of esketamine and dexmedetomidine, the parturients may experience nightmares, dizziness, hallucinations, and drowsiness, etc.
- 1 June 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 2381-2392
Open AccessEsketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study
Purpose: We aimed to evaluate the effect of intravenous esketamine combined with dexmedetomidine as supplemental analgesia in reducing intraoperative visceral pain during elective cesarean section under combined spinal-epidural anesthesia (CSEA). Patients and Methods: A total of 269 parturients scheduled for elective cesarean section under CSEA between May 2023 and August 2023 were assessed. The parturients were randomly allocated to receiving either intravenous infusion of 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine (group ED, n=76), 0.5-μg/kg dexmedetomidine (group D, n=76), or normal saline (group C, n=76) after umbilical cord clamping. The primary outcome was intraoperative visceral pain. Secondary outcomes included the visual analog scale (VAS) score for pain evaluation and other intraoperative complications. Results: The incidence of visceral pain was lower in group ED [9 (12.7%)] than in group D [32 (43.8%)] and group C [36 (48.6%), P < 0.0001]. The VAS score was also lower in group ED when exploring abdominal cavity [0 (0), P < 0.0001] and suturing the muscle layer [0 (0), P =0.036]. The mean arterial pressure was higher in group D [83 (9) mmHg] and group ED [81 (11) mmHg] than in group C [75 (10) mmHg, P < 0.0001] after solution infusion. The heart rate after infusion of the solution was lower in group D [80 (12) bpm] than in group C [86 (14) bpm] and group ED [85 (12) bpm, P = 0.016]. The incidence of transient neurologic or mental symptoms was higher in group ED compared to group C and group D (76.1% vs 18.9% vs 23.3%, P< 0.0001). Conclusion: During cesarean section, 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine can alleviate visceral traction pain and provide stable hemodynamics. Parturients receiving this regimen may experience transient neurologic or mental symptoms that can spontaneously resolve at the end of the surgery. Plain Language Summary: Some parturients endure experience indescribable pain and discomfort during fetal delivery. Esketamine combined with dexmedetomidine can alleviate this pain during cesarean section under combined spinal-epidural anesthesia. However, after intravenous injection of esketamine and dexmedetomidine, the parturients may experience nightmares, dizziness, hallucinations, and drowsiness, etc.
- Open Access
- 14 February 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (2) , e1187
Association between preoperative systemic immune inflammation index and postoperative sepsis in patients with intestinal obstruction: A retrospective observational cohort study
Background: Sepsis is a severe complication that results in increased morbidity and mortality after intestinal obstruction surgery. This study examined the role of preoperative systemic immune inflammation index (SII) for postoperative sepsis in intestinal obstruction patients.Methods: Data on patients who underwent intestinal obstruction surgery were collected. SII was determined and separated into two groups (≤1792.19 and >1792.19) according to the optimal cut‐off value of SII for postoperative sepsis. The odds ratio (OR) is calculated for the correlation between SII and postoperative sepsis. Additional analyses were used to estimate the robustness of SII.Results: A total of 371 intestinal obstruction patients undergoing surgery were included in the final cohort, and 60 (16.17%) patients developed postoperative sepsis. Patients with an SII >1792.19 had a significantly higher risk for developing postoperative sepsis after multivariable adjustment [adjusted odds ratio = 2.12, 95% confidence interval: [1.02–4.40]]. The analysis of interaction showed no correlation between the preoperative SII and postoperative sepsis regarding age, hypertension, American Society of Anesthesiologists classification, blood loss, albumin, hemoglobin, creatinine, and leukocyte (all interactions p > .05). In subgroup analysis, all statistically significant subgroups showed that SII was a risk factor for postoperative sepsis (all p < .05). The analyses of subgroups and interactions revealed that the interaction effect of a preoperative SII >1792.19 and postoperative sepsis remained significant. A sensitivity analysis confirmed the robustness of the results.Conclusions: A preoperative SII > 1792.19 was a risk factor for postoperative sepsis in patients undergoing intestinal obstruction surgery.
- 14 February 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (2) , e1187
Open AccessAssociation between preoperative systemic immune inflammation index and postoperative sepsis in patients with intestinal obstruction: A retrospective observational cohort study
Background: Sepsis is a severe complication that results in increased morbidity and mortality after intestinal obstruction surgery. This study examined the role of preoperative systemic immune inflammation index (SII) for postoperative sepsis in intestinal obstruction patients.Methods: Data on patients who underwent intestinal obstruction surgery were collected. SII was determined and separated into two groups (≤1792.19 and >1792.19) according to the optimal cut‐off value of SII for postoperative sepsis. The odds ratio (OR) is calculated for the correlation between SII and postoperative sepsis. Additional analyses were used to estimate the robustness of SII.Results: A total of 371 intestinal obstruction patients undergoing surgery were included in the final cohort, and 60 (16.17%) patients developed postoperative sepsis. Patients with an SII >1792.19 had a significantly higher risk for developing postoperative sepsis after multivariable adjustment [adjusted odds ratio = 2.12, 95% confidence interval: [1.02–4.40]]. The analysis of interaction showed no correlation between the preoperative SII and postoperative sepsis regarding age, hypertension, American Society of Anesthesiologists classification, blood loss, albumin, hemoglobin, creatinine, and leukocyte (all interactions p > .05). In subgroup analysis, all statistically significant subgroups showed that SII was a risk factor for postoperative sepsis (all p < .05). The analyses of subgroups and interactions revealed that the interaction effect of a preoperative SII >1792.19 and postoperative sepsis remained significant. A sensitivity analysis confirmed the robustness of the results.Conclusions: A preoperative SII > 1792.19 was a risk factor for postoperative sepsis in patients undergoing intestinal obstruction surgery.
- 9 February 2024
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (5) , 656-661
Simultaneous cholecystectomy for asymptomatic gallstones during elective colorectal cancer surgery
- 9 February 2024
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (5) , 656-661
Simultaneous cholecystectomy for asymptomatic gallstones during elective colorectal cancer surgery
- Open Access
- 30 March 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 906514
Association between intraoperative dexmedetomidine and all-cause mortality and recurrence after laparoscopic resection of colorectal cancer: Follow-up analysis of a previous randomized controlled trial
Background: Dexmedetomidine (DEX) has been widely applied in the anesthesia and sedation of patients with oncological diseases. However, the potential effect of DEX on tumor metastasis remains contradictory. This study follows up on patients who received intraoperative DEX during laparoscopic resection of colorectal cancer as part of a previous clinical trial, examining their outcomes 5 years later.Methods: Between June 2015 and December 2015, 60 patients undergoing laparoscopic colorectal resection were randomly assigned to the DEX and control groups. The DEX group received an initial loading dose of 1μ/kg before surgery, followed by a continuous infusion of 0.3μg/kg/h during the operation and the Control group received an equivalent volume of saline. A 5-year follow-up analysis was conducted to evaluate the overall survival, disease-free survival, and tumor recurrence.Results: The follow-up analysis included 55 of the 60 patients. The DEX group included 28 patients, while the control group included 27 patients. Baseline characteristics were comparable between the two groups, except for vascular and/or neural invasion of the tumor in the DEX group (9/28 vs. 0/27, p = 0.002). We did not observe a statistically significant benefit but rather a trend toward an increase in overall survival and disease-free survival in the DEX group, 1-year overall survival (96.4% vs. 88.9%, p = 0.282), 2-year overall survival (89.3% vs. 74.1%, p = 0.144), 3-year overall survival (89.3% vs. 70.4%, p = 0.08), and 5-year overall survival (78.6% vs. 59.3%, p = 0.121). The total rates of mortality and recurrence between the two groups were comparable (8/28 vs. 11/27, p = 0.343).Conclusion: Administration of DEX during laparoscopic resection of colorectal cancer had a nonsignificant trend toward improved overall survival and disease-free survival.Clinical Trial Registration: http://www.chictr.org.cn/, identifier ChiCTRIOR-15006518.
- 30 March 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 906514
Open AccessAssociation between intraoperative dexmedetomidine and all-cause mortality and recurrence after laparoscopic resection of colorectal cancer: Follow-up analysis of a previous randomized controlled trial
Background: Dexmedetomidine (DEX) has been widely applied in the anesthesia and sedation of patients with oncological diseases. However, the potential effect of DEX on tumor metastasis remains contradictory. This study follows up on patients who received intraoperative DEX during laparoscopic resection of colorectal cancer as part of a previous clinical trial, examining their outcomes 5 years later.Methods: Between June 2015 and December 2015, 60 patients undergoing laparoscopic colorectal resection were randomly assigned to the DEX and control groups. The DEX group received an initial loading dose of 1μ/kg before surgery, followed by a continuous infusion of 0.3μg/kg/h during the operation and the Control group received an equivalent volume of saline. A 5-year follow-up analysis was conducted to evaluate the overall survival, disease-free survival, and tumor recurrence.Results: The follow-up analysis included 55 of the 60 patients. The DEX group included 28 patients, while the control group included 27 patients. Baseline characteristics were comparable between the two groups, except for vascular and/or neural invasion of the tumor in the DEX group (9/28 vs. 0/27, p = 0.002). We did not observe a statistically significant benefit but rather a trend toward an increase in overall survival and disease-free survival in the DEX group, 1-year overall survival (96.4% vs. 88.9%, p = 0.282), 2-year overall survival (89.3% vs. 74.1%, p = 0.144), 3-year overall survival (89.3% vs. 70.4%, p = 0.08), and 5-year overall survival (78.6% vs. 59.3%, p = 0.121). The total rates of mortality and recurrence between the two groups were comparable (8/28 vs. 11/27, p = 0.343).Conclusion: Administration of DEX during laparoscopic resection of colorectal cancer had a nonsignificant trend toward improved overall survival and disease-free survival.Clinical Trial Registration: http://www.chictr.org.cn/, identifier ChiCTRIOR-15006518.
- Open Access
- 1 January 2023
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 20 (8) , 1114
Exosomes Released by Bone Marrow Mesenchymal Stem Cells Attenuate Lung Injury Induced by Intestinal Ischemia Reperfusion via the TLR4/NF-κB Pathway: Erratum
[This corrects the article DOI: 10.7150/ijms.35369.].
- 1 January 2023
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 20 (8) , 1114
Open AccessExosomes Released by Bone Marrow Mesenchymal Stem Cells Attenuate Lung Injury Induced by Intestinal Ischemia Reperfusion via the TLR4/NF-κB Pathway: Erratum
[This corrects the article DOI: 10.7150/ijms.35369.].
- 16 December 2022
- Published by Elsevier in Tissue and Cell
- Vol. 80, 102001
Culture media from hypoxia conditioned mast cells aggravates hypoxia and reoxygenation injury of human intestinal cells
- 16 December 2022
- Published by Elsevier in Tissue and Cell
- Vol. 80, 102001
Culture media from hypoxia conditioned mast cells aggravates hypoxia and reoxygenation injury of human intestinal cells